Luque, A. E., Cohn, S. E., Park, J., Cramer, Y., Weinberg, A., Livingston, E., . . . Watts, D. H. (2015). Depot Medroxyprogesterone Acetate in Combination with a Twice-Daily Lopinavir-Ritonavir-Based Regimen in HIV-Infected Women Showed Effective Contraception and a Lack of Clinically Significant Interactions, with Good Safety and Tolerability: Results of the ACTG 5283 Study. Antimicrob Agents Chemother.

Luque, Amneris E., Susan E. Cohn, Jeong-Gun Park, Yoninah Cramer, Adriana Weinberg, Elizabeth Livingston, Karin L. Klingman, Francesca Aweeka, and D. Heather Watts. "Depot Medroxyprogesterone Acetate in Combination With a Twice-Daily Lopinavir-Ritonavir-Based Regimen in HIV-Infected Women Showed Effective Contraception and a Lack of Clinically Significant Interactions, With Good Safety and Tolerability: Results of the ACTG 5283 Study." Antimicrob Agents Chemother 2015.

Luque, Amneris E., et al. "Depot Medroxyprogesterone Acetate in Combination With a Twice-Daily Lopinavir-Ritonavir-Based Regimen in HIV-Infected Women Showed Effective Contraception and a Lack of Clinically Significant Interactions, With Good Safety and Tolerability: Results of the ACTG 5283 Study." Antimicrob Agents Chemother 2015.